Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

6.980 -0.500 (-6.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)
From Kirby McInerney LLP
Via Business Wire
Dow Surges 350 Points; Fed Holds Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... 
Via Benzinga
Preview: Lifecore Biomedical's Earnings
Via Benzinga
Recap: Lifecore Biomedical Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher
U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P... 
Via Benzinga
Topics Economy Stocks
Exposures Fossil Fuels Interest Rates US Equities
US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views
U.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.01% to 39,106.88 while the NASDAQ... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Preview: Lifecore Biomedical's Earnings
Via Benzinga
Analyst Ratings for Lifecore Biomedical
Via Benzinga
Why Lifecore Biomedical Shares Are Skyrocketing Today
Via Benzinga
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Top 5 Risk Off Stocks That May Explode This Quarter
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Lifecore Biomedical Provides Business Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
U.S. Department of Justice Declines Prosecution 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Top 5 Risk Off Stocks That May Plunge In Q2
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Lifecore Biomedical Q3 Misses Street Estimates, Explores 'Strategic Alternatives'
Lifecore Biomedical Inc (NASDAQ: LFCR) reported a Q3 FY23 revenue decline of 26% Y/Y to $27.60 million, 
Via Benzinga
Earnings Scheduled For June 1, 2023
Companies Reporting Before The Bell • Hormel Foods (NYSE:HRL) is likely to report quarterly earnings at $0.40 per share on revenue of $3.05 billion. 
Via Benzinga
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
Going concern qualification is removed as a result of the $150 million new financing transaction announced last week 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.